BK

Bernhard Kirschbaum

Supervisory Board Chairman at OMEICOS Therapeutics

Bernhard Kirschbaum studied biochemistry and physiological chemistry at the University of Konstanz and received his PhD in 1989. He moved on to work at the Rockefeller University and the Pasteur Institute before making a career in the pharmaceutical industry where he covered a broad range of technological and disease areas. In his most recent position, Dr. Kirschbaum served as head of Global Research and Early Development at Merck Serono where he was a member of the board.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


OMEICOS Therapeutics

OMEICOS Therapeutics is developing a novell molecule utilizing a new Mode of Action for the treatment and prevention of atrial fibrillation.


Headquarters

Berlin, Germany

Employees

11-50

Links